title: Medical records and quality of care in acute coronary syndromes: results from CRUSADE.
abstract: BACKGROUND
  Patient medical records are important means of communication among health care providers. Limited evaluation has been performed of the quality of the medical records or its association with health care processes or outcomes.
  
  
  METHODS
  We performed an empirical evaluation of the completeness of medical records from 607 randomly selected patients admitted with non-ST-segment elevation acute coronary syndromes (NSTE ACS) to 219 US hospitals in the CRUSADE National Quality Improvement Initiative. Composite medical records scores were summated and compared by hospital academic status and physician specialty. Correlations between medical records scores, use of evidence-based medicine (EBM), and in-hospital mortality were assessed.
  
  
  RESULTS
  Medical records were frequently missing key elements, including cardiac history (23.6%), performance status (64.6%), differential diagnosis (57.8%), and planned use of EBM (44.0%). Evidence-based medicine was more often discussed in medical records from academic medical centers vs nonacademic medical centers (69.7% vs 51.7%) (P < .001) and from cardiologists vs noncardiologists (60.5% vs 48.1%, P = .003). Higher medical records quality scores were associated with greater use of EBM among the medical records quality cohort (P = .006), and a similar trend was observed in CRUSADE overall: adjusted odds ratio, 1.26 (95% confidence interval, 0.92-1.72) for high vs low medical records quality. Higher medical records quality scores were associated with lower in-hospital mortality: adjusted odds ratio, 0.79 (95% confidence interval, 0.65-0.97).
  
  
  CONCLUSIONS
  Medical records for patients with NSTE ACS often lack key elements of the history and physical examination. Patients treated at hospitals with better medical records quality have significantly lower mortality and may receive more EBM. The relationship between better medical charting and better medical care could lead to new ways to monitor and improve the quality of medical care.
authors.affiliation: Department of Medicine, Duke University Medical Center, Durham, NC, USA. smdunlay@gmail.com
authors.forename: Shannon M
authors.initials: SM
authors.lastname: Dunlay
authors.forename: Karen P
authors.initials: KP
authors.lastname: Alexander
authors.forename: Chiara
authors.initials: C
authors.lastname: Melloni
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Kraschnewski
authors.forename: Li
authors.initials: L
authors.lastname: Liang
authors.forename: W Brian
authors.initials: WB
authors.lastname: Gibler
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Roe
authors.forename: E Magnus
authors.initials: EM
authors.lastname: Ohman
authors.forename: Eric D
authors.initials: ED
authors.lastname: Peterson
mesh_terms: D000046:Academic Medical Centers; D054058:Acute Coronary Syndrome / Q000188:drug therapy / Q000453:epidemiology*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005260:Female; D005568:Forms and Records Control / Q000592:standards; D019983:Guideline Adherence; D006493:Heparin / Q000627:therapeutic use; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008499:Medical Records / Q000592:standards*; D008511:Medicine; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care; D013038:Specialization; D014481:United States / Q000453:epidemiology
chemical_list: D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D006493:Heparin